Two-week-old human embryos reveal origin of Huntington’s disease
Scientists have discovered a signalling pathway alteration in embryos with Huntington’s disease, paving the way for ground-breaking treatments.
List view / Grid view
Scientists have discovered a signalling pathway alteration in embryos with Huntington’s disease, paving the way for ground-breaking treatments.
11 December 2015 | By Victoria White
The study will look at the safety and tolerability of PnuBioVax for three different dosages against the bacterial pathogen Streptococcus pneumoniae...
1 December 2015 | By Victoria White
With Universal Cells’ proprietary gene editing technology, Adaptimmune intends to develop affinity enhanced donor T-cells...
25 September 2015 | By Victoria White
When eCD4-lg was tested in animal models, the results were so powerful and effective that they suggested the compound’s potential to serve the role of an alternative HIV/AIDS vaccine...
25 August 2015 | By Victoria White
Scientists from The Scripps Research Institute (TSRI) and Janssen have found a way to induce antibodies to fight a wide range of influenza subtypes...
10 August 2015 | By Charlotte Batchelor, Drug Target Review
Twelve new treatments, diagnostics and medical technologies will receive funding from the eighth round of the successful Biomedical Catalyst (BMC)...
31 July 2015 | By Victoria White
Researchers have identified a new mechanism that the tumour suppressor protein p53 uses to trigger cell death via apoptosis...
3 July 2015 | By Victoria White
New research suggests it may be possible to harness a previously unknown mechanism within the immune system to create more effective flu vaccines...
3 June 2015 | By Victoria White
Inovio has said it will advance its DNA vaccine for MERS into a Phase I clinical trial in healthy volunteers in a collaboration with GeneOne Life Science...
17 December 2014 | By MRC Technology
Structure-based drug discovery platform targets challenging GPCRs linked to human disease...
15 October 2014 | By Seahorse Bioscience
Seahorse Bioscience and the University of Alabama at Birmingham announced that they have entered into a partnership to study the bioenergetic health of cells in cryo-preserved blood – a step that will ultimately produce a first-of-its-kind clinical test of metabolic bioenergetic health...